phrase "pain as the fifth vital sign." 4, 5 Additional initiatives by the Veterans Health Administration and the Joint Commission (formerly known as the Joint Commission on Accreditation of Healthcare Organizations) ushered in the paradigm shift in providers treating chronic pain with prescription opioid medication [4] [5] [6] [7] . The ramifications of increased opioid prescribing appeared soon after when, in 2008, drug overdoses surpassed automobile collisions as the leading cause of accidental death in the United States 8 . In 2015, opioids were involved in 33,091 deaths, the highest number in a year to date 7 . Almost half of these deaths involved a prescription opioid 8 . The remaining deaths resulted from heroin use, and approximately 70% of heroin users cite use of a prescribed opioid as the inciting cause of their addiction 9 . Federal and state government agencies have instituted multiple programs to regulate and track opioid-prescribing practices 10, 11 . One important goal of these programs is to reduce the excess amount of opioid medications prescribed to patients, as illicit diversion of these medications may be a substantial contributor to opioid-related abuse 11 . The burden of postoperative musculoskeletal pain is substantial, and appropriate use of opioid medication in its treatment remains a goal for practitioners [12] [13] [14] . Recent studies in the orthopaedic literature have highlighted that substantial variation and overprescribing occur after surgical procedures [15] [16] [17] [18] . For example, Kim et al. showed that patients undergoing an upper-extremity surgical procedure used only 34% of the opioid medications prescribed 18 . Orthopaedic surgeons are the third-highest group of opioid prescribers among physicians, accounting for almost 8% of all opioid prescriptions in the United States 6 . The orthopaedic literature has presented trends and risk factors associated with opioid use following surgical procedures [19] [20] [21] [22] [23] [24] . Recent studies have Study flow diagram demonstrating inclusion in prescribing data review, inclusion in telephone survey, attrition from lack of telephone contact, and exclusion at each stage of the study. THA = total hip arthroplasty, TKA = total knee arthroplasty, CTR = endoscopic carpal tunnel release, RCR = arthroscopic rotator cuff repair, LD = lumbar decompression (with or without arthrodesis), EMR = electronic medical record, and FY = fiscal year.
highlighted a pattern of patients receiving excess opioid medication after undergoing orthopaedic surgery; however, to our knowledge, there have been few data to suggest an optimal supply of pain medication postoperatively 18, 25, 26 . We are aware of no comprehensive guide to inform surgeons on typical opioid consumption following common orthopaedic procedures.
The purpose of this study was to determine how much postoperative pain medication was being prescribed, how much of the medication was being taken, and the minimal number of opioid pills optimally needed to treat postoperative pain following 5 common elective orthopaedic procedures.
Materials and Methods

Study Design
I nternal review board approval was obtained prior to the initiation of the study. We obtained prescribing data from the electronic medical records of all patients undergoing the 5 most commonly performed elective orthopaedic procedures at our institution in fiscal year (FY) 2015: total hip arthroplasty, total knee arthroplasty, endoscopic carpal tunnel release, arthroscopic rotator cuff repair, and lumbar spine decompression (laminectomy, facetectomy, and foraminotomy with or without arthrodesis).
Our data set included patients treated by 15 fellowshiptrained orthopaedic surgeons.
We included all adult ( ‡18 years of age), English-speaking patients who were followed postoperatively for a minimum of 90 days and for whom postoperative prescription data were available. We excluded trauma cases and any patients who underwent a revision procedure for any reason. Also excluded were patients who underwent simultaneous bilateral procedures. For patients who underwent staged bilateral procedures, we included both procedures. Patients who continued to require prescription opioid medication for postoperative pain control for >90 days postoperatively were excluded from our aggregate calculations. These patients were removed from aggregate calculations based on established expectations for postoperative opioid 
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T 7, 2018 independence and our department's protocol for involving chronic pain specialists in opioid management for those requiring continued opioid prescriptions at 90 days postoperatively 20, 27 . Using the prescribing data recorded in the electronic medical records, we recorded the number, dosage, and formulation of opioid medication prescribed upon discharge from our facility. Detailed refill data were also recorded to calculate the entire duration and amount of postoperative opioid therapy. Using opioid equianalgesic charts, we converted dosages to an oxycodone 5-mg standard to better assess the number of pills prescribed 28, 29 . We also noted whether or not the patient had been taking opioids in the 30-day period prior to the surgical procedure.
For the second portion of the study, we conducted telephone interviews of patients who met our inclusion criteria and had undergone the surgical procedure in the second half of FY2015 to obtain information with regard to opioid utilization and pain management satisfaction. We contacted eligible patients using telephone numbers recorded in the electronic medical record and classified respondents as "could not be reached" if we were unable to reach a respondent after 5 telephone attempts. The data were captured using a uniform telephone survey and were modeled using an equation derived by Hill et al. in a report on opioid prescribing following general surgical procedures 30 . We asked patients how much of their opioid medication was remaining after they completed recovery and assigned "% remaining" estimations based on their responses. Patients who had a full prescription remaining were assigned 100% remaining. Patients who had more than half but not a full prescription remaining were assigned 75% remaining. Patients who had less than half but not an empty prescription remaining were assigned 25% remaining. Patients who had no pills remaining were assigned 0% remaining 30 . We multiplied these percentages by the number of pills last prescribed to determine the excess number of pills.
We additionally queried patients on methods of disposal of unconsumed pills. We offered 4 choices to account for their excess pills: (1) had appropriately disposed of the pills; (2) still had excess pills; (3) did not know what happened to the pills; and (4) other. If patients reported that they still had remaining pills, we instructed them on appropriate disposal methods using the U.S. Food and Drug Administration (FDA) official recommendations for opioid disposal 31 .
Statistical Methods
We assessed age for distribution and association with the respective procedure using the Student t test. Categorical variables (sex, race, preoperative opioid use) were evaluated using the chi-square test and are presented using counts and percentages. After calculating summary statistics of the prescribing data, we calculated the number of pills prescribed on discharge, the overall number of pills prescribed, and the overall number of pills taken using the percentage remaining data from the telephone surveys. Distributions of the total number of pills taken per procedure were plotted, facilitating an analysis of prescribing numbers, refill rates, and projected excess pill numbers. Additional outcome measures including refill rates, the number of unconsumed pills, and satisfaction scores were adjusted for the main covariates (age, sex, preoperative opioid use).
We conducted a subanalysis of survey responses regarding postoperative satisfaction with pain control by surgical procedure by performing multivariate logistic regression with relevant covariates. We also performed an adjusted multivariate logistic regression on patients who continued to take opioid medication longer than 90 days postoperatively to identify any association with the procedure and preoperative opioid use.
Finally, we performed a multivariate adjusted linear regression to determine which exposures proved to be significant, which was defined as p < 0.05, in their association with the total number of postoperative opioid pills prescribed.
Results
Prescribing Data
I n our study, 1,199 procedures on 1,159 distinct patients met the inclusion and exclusion criteria for review of prescription data following an orthopaedic surgical procedure. The number of cases for each elective procedure was 421 for total hip arthroplasty, 286 for total knee arthroplasty, 216 for endoscopic carpal tunnel release, 146 for arthroscopic rotator cuff repair, and 130 for lumbar decompression (Fig. 1) . Forty-seven patients were then excluded from primary analysis for postoperative opioid use that continued for >90 days postoperatively.
For the patient's initial discharge prescription, providers prescribed opioid pills (oxycodone 5-mg equivalent) at a median of 90 pills (range, 20 to 330 pills) following total hip arthroplasty, a median of 90 pills (range, 10 to 200 pills) following total knee arthroplasty, a median of 20 pills (range, 0 to 
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T 7, 2018 168 pills) following endoscopic carpal tunnel release, a median of 80 pills (range, 18 to 100 pills) following arthroscopic rotator cuff repair, and a median of 80 pills (range, 10 to 270 pills) following lumbar decompression. Thirty-seven percent of patients overall requested and received at least 1 refill prescription within the initial 90-day postoperative period (Table I) .
The mean number of opioid pills prescribed (and standard deviation) including refills was 113.6 ± 75.7 (range, 30 to 560) for patients undergoing total hip arthroplasty, 176.4 ± 108.0 (range, 10 to 480) for patients undergoing total knee arthroplasty, 24.3 ± 29.0 (range, 0 to 220) for patients undergoing endoscopic carpal tunnel release, 98.2 ± 59.6 (range, 30 to 435) for patients undergoing arthroscopic rotator cuff repair, and 107.4 ± 64.4 (range, 14 to 364) for patients undergoing lumbar decompression (Fig. 2) .
Survey Results
From the second half of FY2015, 682 patients were eligible to be included in the telephone survey portion of the study, and 557 patients participated in the survey questions. Of the 125 nonparticipants, 75 could not be reached, 25 did not wish to participate, and 25 had died (Fig. 1) . At 17.6%, survey participants had a lower recorded percentage of preoperative opioid use (p = 0.039) compared with nonparticipants at 24.0%; there were no other documented differences between the populations.
Using the respondents' answers to the question regarding the amount of opioid prescription remaining, we were able to calculate the sum of all opioids prescribed (first prescription 
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T 7, 2018 and refills) and to subtract the excess pills reported (the percentage remaining multiplied by the final prescription number), giving us the amount of medication taken. The mean total number of opioid pills taken was 80.8 ± 83.8 pills for patients undergoing total hip arthroplasty, 146.9 ± 116.4 pills for patients undergoing total knee arthroplasty, 15.9 ± 32.0 pills for patients undergoing endoscopic carpal tunnel release, 79.8 ± 88.8 pills for patients undergoing arthroscopic rotator cuff repair, and 70.7 ± 62.0 pills for patients undergoing lumbar decompression (Table II) . Participants reported having unused opioid medication in 61% (340 of 557) of the cases. The mean number of unconsumed pills was 31.9 pills for patients undergoing total hip arthroplasty, 28.9 pills for patients undergoing total knee arthroplasty, 11.2 pills for patients undergoing endoscopic carpal tunnel release, 25.5 pills for patients undergoing arthroscopic rotator cuff repair, and 29.3 pills for patients undergoing lumbar decompression (Table II) . Applying these mean unconsumed amounts to the overall number of patients undergoing these procedures at our institution in a single fiscal year results in an estimated 43,216 unused pills.
Patient satisfaction with postoperative pain control was generally high for all 5 procedures as they all registered a >83% overall satisfaction rate (defined by measures of 4 "somewhat satisfied" or 5 "very satisfied" on a 5-point Likert scale) (Fig. 3) . Satisfaction was highest for endoscopic carpal tunnel release (mean, 4.8 of 5) and lowest for lumbar decompression (mean, 4.3 of 5). Logistic regression of postoperative satisfaction demonstrated a significant increase in satisfaction associated with patients who were >75 years of age compared with a reference group of patients who were <55 years of age (odds ratio [OR], 2.70; p = 0.011). Preoperative opioid use was not associated with satisfaction (OR, 1.00; p = 0.986).
When asked about unused opioid disposal, 41% of patients stated that they had appropriately disposed of excess pills, 15% stated that they still had the excess pills, 8% said that they did not know what happened to the excess pills, and 36% said "other" (Fig. 4) .
Chronic Postoperative Opioid Use
Forty-seven patients continued to use opioid medications chronically for more than 90 days postoperatively (confirmed by an opioid prescription in the electronic medical record dated postoperative day 91 or later). Twenty-seven of these patients had been taking opioids preoperatively. As the remaining 20 patients had not been using opioid medications preoperatively, this implies that postoperative pain control contributed to chronic opioid use in approximately 2.0% (20 of 988 of the patients who were not taking opioids preoperatively and postoperatively) of our patients who were opioidnaïve preoperatively but became chronic opioid users postoperatively. 
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Multivariate logistic regression, adjusted for age, showed a significant association of increased risk of chronic postoperative opioid use in patients who were taking opioids preoperatively (OR, 6.55; p < 0.001). A significantly lower risk of chronic postoperative use was associated with older age when patients who were 65 to 74 years of age were compared with patients who were <55 years of age (OR, 0.12; p < 0.001) and patients who were 75 to 92 years of age were compared with patients who were <55 years of age (OR, 0.10; p = 0.002). Additionally, patients undergoing total knee arthroplasty had significant association of increased chronic postoperative use compared with patients undergoing rotator cuff repair, carpal tunnel release, or lumbar decompression (Table III) .
Discussion
I
n an evaluation of the 5 most common elective orthopaedic procedures performed at our institution, we found that postoperative opioid-prescribing patterns varied widely among procedures and tended to provide patients with an excess of pills approximately 60% of the time. Our findings show that, during FY2015, an excess of approximately 43,000 opioid pills were prescribed following the 5 most common elective orthopaedic procedures at our institution. Patients who had undergone total knee arthroplasty had the highest mean number of postoperative opioid pills at 176.4 (including refills), and patients who had undergone total hip arthroplasty had the largest mean number of remaining pills at 31.9 per patient. The widest range in total pills prescribed was among patients who had undergone total hip arthroplasty, ranging from 30 to 560 postoperatively.
A limitation of our study was the broad scope that we applied to capture prescribing and utilization trends in elective procedures. There are meaningful differences within surgical procedures and the preoperative status of individual patients 
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that we did not assess in this study. Previous studies have demonstrated that patients who undergo upper-extremity, soft-tissue procedures tend to use less opioid pain medication than those who undergo osseous procedures 18, 32 . We did not stratify for incorporation of additional osseous procedures (for example, subacromial decompression) in the patients who had undergone arthroscopic rotator cuff repair. Similarly, we did not evaluate surgical intensity or surgical approach, and we made the broad assumption that cases within the same primary Current Procedural Terminology (CPT) code were generally the same.
Another limitation was our reliance on patient recall in capturing excess medication counts. Although we focused our surveys on patients who had undergone a surgical procedure between March and September 2015, it is still reasonable to expect some recall error from patients attempting to remember the events from as long as 14 months prior. Finally, our patient population tended to be fairly homogenous with regard to patient race and ethnicity, which could have limited the generalizability of our findings.
One trend that emerged from our data was a detectable bimodal distribution of postoperative opioid consumption. Approximately half of the patients for each given procedure utilized a fraction of their initial prescription, and the other half of patients used their full initial prescription or received refills for additional medication (Fig. 5) . Some of this variation in use may be due to the intensity of the procedure (in the case of a shoulder arthroscopy or a spine surgical procedure) 18, 33 . In the case of patients undergoing total hip arthroplasty or total knee arthroplasty, other explanations as to why certain patients require less (or more) pain medication for similar procedures warrant further investigation.
We did not find a correlation between preoperative opioid use and decreased satisfaction with postoperative pain control. This finding is not generally supported by most current studies that demonstrate preoperative use of opioids portends worse outcomes following a surgical procedure 23, 34, 35 . One explanation for the absence of correlation may be our overall high satisfaction rates. With a range of 84% to 95% satisfaction in postoperative pain management among the 5 procedures, we had a small sample size of dissatisfied patients in which to detect an association. This finding may strike at a foundation of the current opioid abuse crisis: the high number of opioids prescribed may promote greater patient satisfaction while simultaneously fueling the problems of excess opioid use and increased risk of opioid diversion.
Our study appears to be unique with regard to the number of cases captured, the number of patients surveyed, and the breadth of procedural categories. To our knowledge, this study is also the first to quantify the volume of excess opioid pills distributed by an orthopaedic surgery department following common elective procedures. Our determination that an excess of 43,000 opioid pills were prescribed in the course of 1 year highlights the magnitude of the contribution of orthopaedic surgery to the ongoing epidemic of opioid abuse and diversion. Additionally, Cicero et al. demonstrated that white patients living in nonurban areas who previously abused prescription opioid medications represent the majority of new heroin users in the United States 36 . Indeed, the setting of our institution in a rural New England community with a predominantly white patient base serves as a microcosm for the exponential rise in heroin abuse.
The findings in this study may be a useful guide to postoperative opioid protocols by establishing a standard number of opioid pills following elective orthopaedic procedures. By prescribing an amount slightly below the recorded median value in this study (for example, prescribing 70 opioid pills upon discharge for total hip arthroplasty), providers could potentially meet the pain control demands of more than half of their patients while lowering the amount of excess medication prescribed.
Multiple authors have proposed ways to approach stratifying potential pain control issues following an orthopaedic surgical procedure based on characteristics of the surgical procedure and the patient risk factors for chronic opioid use 25, 32 . We believe that better prescribing protocols should be developed following orthopaedic procedures to curb overprescribing and the detrimental impact that it can have on the community. n
